EX-99.1 2 d63345dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

BURGUNDY TECHNOLOGY ACQUISITION CORPORATION.

BALANCE SHEET

 

     August 31, 2020     Pro Forma
Adjustments
          As Adjusted  
           (Unaudited)           (Unaudited)  

Assets

        
Current assets:                         

Cash

   $ 2,002,000     $ 45,000,000       (a   $ 2,002,000  
       1,125,000       (b  
       (900,000     (c  
       (45,225,000     (f  

Prepaid expenses

     180,000       —           180,000  
  

 

 

   

 

 

     

 

 

 

Total current assets

     2,182,000       —           2,182,000  

Cash held in Trust Account

     301,500,000       45,225,000       (f     346,725,000  
  

 

 

   

 

 

     

 

 

 

Total assets

   $  303,682,000     $ 45,225,000       $  348,907,000  
  

 

 

   

 

 

     

 

 

 
Liabilities and Shareholders’ Equity                         
Current liabilities:                         

Accounts payable

   $ 22,613       —         $ 22,613  

Accrued expenses

     634,270       —           634,270  

Note payable - related party

     188,213       —           188,213  
  

 

 

   

 

 

     

 

 

 

Total current liabilities

     845,096       —           845,096  

Deferred underwriting commissions

     10,500,000       1,575,000       (d     12,075,000  
  

 

 

   

 

 

     

 

 

 

Total liabilities

     11,345,096       1,575,000         12,920,096  
Commitments and Contingencies                         

Class A ordinary shares, $0.0001 par value; 28,590,736 and 32,934,020 shares subject to possible redemption at $10.05 per share, actual and as adjusted, respectively

     287,336,897       43,650,004       (e     330,986,901  
Shareholders’ Equity:                         

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

     —         —           —    

Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,359,264 and 2,628,480 shares issued and outstanding (excluding 32,934,020 shares subject to possible redemption), actual and as adjusted, respectively

     236       450       (a     263  
       11       (b  
       (434     (e  

Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding, actual and as adjusted (1)

     863       —           863  

Additional paid-in capital

     5,083,446       44,999,550       (a     5,083,415  
       1,124,989       (b  
       (900,000     (c  
       (1,575,000     (d  
       (43,649,570     (e  

Accumulated deficit

     (84,538     —           (84,538
  

 

 

   

 

 

     

 

 

 

Total shareholders’ equity

     5,000,007       (4       5,000,002  
  

 

 

   

 

 

     

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 303,682,000     $ 45,225,000       $ 348,907,000  
  

 

 

   

 

 

     

 

 

 

The accompanying notes are an integral part of these financial statements.


NOTE 1- CLOSING OF OVER-ALLOTMENT OPTION AND ADDITIONAL PRIVATE PLACEMENT

The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of Burgundy Technology Acquisition Corporation. (the “Company”) as of August 31, 2020, adjusted for the closing of the underwriters’ over-allotment option and related transactions which occurred on September 18, 2020 as described below.

The Company consummated its initial public offering (the “IPO”) of 30,000,000 units (the “Units”). Each Unit consists of one ordinary share, par value $0.0001 per share (“Ordinary Shares”), and one-half of one warrant (“Warrant”), each whole Warrant exercisable to purchase one Ordinary Share at an exercise price of $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $300.0 million. The Company granted the underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 4,500,000 additional Units to cover over-allotments, if any. The Underwriters exercised the over-allotment option in full and on September 18, 2020 purchased an additional 4,500,000 Units (the “Over-Allotment Units”), generating gross proceeds of $45.0 million, and incurred additional offering costs of approximately $2.5 million in underwriting fees (inclusive of approximately $1.6 million in deferred underwriting fees).

Simultaneously with the closing of the IPO, the Company completed a private placement (the “Private Placement”) of an aggregate of 950,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit to Burgundy Technology Sponsor Limited (the “Sponsor”), generating total gross proceeds of $9.5 million, pursuant to the Private Placement Units Purchase Agreement, dated August 26, 2020 (the “Private Placement Purchase Agreement”), by and between the Company and the Sponsor. The Private Placement Purchase Agreement provided for a second closing (the “Second Closing”) of the Private Placement simultaneously with the closing of the Over-Allotment Units. Accordingly, on September 18, 2020, the Second Closing of the Private Placement was consummated, resulting in the purchase of an aggregate of an additional 112,500 Private Placement Units by the Sponsor, generating gross proceeds to the Company of approximately $1.1 million.

In addition, the Sponsor agreed to forfeit up to 1,125,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”) to the extent that the over-allotment option is not exercised in full by the underwriters. The underwriters exercised their over-allotment option on September 18, 2020. As a result, these shares were no longer subject to forfeiture.


Pro forma adjustments to reflect the exercise of the underwriters’ over-allotment option and the sale of the private placement warrants described above are as follows:

 

    

Pro Forma Entries

   Debit      Credit  

(a)

  

Cash

   $ 45,000,000     
  

Class A ordinary shares

      $ 450  
  

Additional paid-in capital

      $ 44,999,550  
  

    To record sale of 4,500,000 Overallotment Units at $10.00 per Unit

     

(b)

  

Cash

   $ 1,125,000     
  

Class A ordinary shares

      $ 11  
  

Additional paid-in capital

      $ 1,124,989  
  

    To record sale of 112,500 Private Placement Units at $10.00 per units

     

(c)

  

Additional paid-in capital

   $ 900,000     
  

Cash

      $ 900,000  
  

    To record payment of 2% of cash underwriting fee on overallotment option

     

(d)

  

Additional paid-in capital

   $ 1,575,000     
  

Deferred underwriting commissions

      $ 1,575,000  
  

    To record additional deferred underwriting fee on overallotment option

     

(e)

  

Class A ordinary shares

   $ 434     
  

Additional paid-in capital

   $ 43,649,570     
  

Class A ordinary shares subject to possible redemption

      $ 43,650,004  
  

    To reclassify Class A ordinary shares out of permanent equity into mezzanine redeemable stock

     

(f)

  

Cash

   $ 45,225,000     
  

Trust account

      $ 45,225,000  
  

    To transfer $10.05 per Overallotment Units to Trust Account